Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non Operating Income: 2020-2022

Historic Other Non Operating Income for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to -$25,650.

  • ADC Therapeutics' Other Non Operating Income rose 18354.94% to $860,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $1.7 million, marking a year-over-year increase of 3902.65%. This contributed to the annual value of -$25,650 for FY2022, which is 26.49% up from last year.
  • Latest data reveals that ADC Therapeutics reported Other Non Operating Income of -$25,650 as of FY2022, which was up 26.49% from -$34,893 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Other Non Operating Income ranged from a high of $45,411 in FY2020 and a low of -$34,893 during FY2021.
  • Over the past 3 years, ADC Therapeutics' median Other Non Operating Income value was -$25,650 (recorded in 2022), while the average stood at -$5,044.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 176.84% in 2021, then climbed by 26.49% in 2022.
  • Over the past 3 years, ADC Therapeutics' Other Non Operating Income (Yearly) stood at $45,411 in 2020, then tumbled by 176.84% to -$34,893 in 2021, then increased by 26.49% to -$25,650 in 2022.